• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
PowerPoint-esitys
PowerPoint-esitys

... studies with similar drugs. Data derived from incomplete case reports and/or in vitro studies. Data derived from well-documented case reports. Data derived from studies among healthy volunteers and/or on pilot studies among ...
DRUG ABSORBPTION
DRUG ABSORBPTION

... The ionization constants give an indication of how strong the acid is. If Ka is large (and hence pKa is small), then at equilibrium, more of the acid will exist in the ionized form. The opposite can be said for bases. If pKa is small for a base, then at equilibrium, more of the base will be in t ...
- deals.bio
- deals.bio

... independent investigation by the recipient. The contents of these materials have not been independently verified by NGDG. NGDG does not make any representation or warranty, express or implied, as to the accuracy or completeness of the information contained in these materials. NGDG expressly disclaim ...
Document
Document

... If a drug is administered intravenously, and then the bioavailability will be ?• .)100% (provided we want the drug to be present in the plasma .The bioavailability can be much less for other routes of administration?• e.g. 500?g of a drug is administered but only 100?g enters the circulation. ?• .Th ...
12598516_ADF DRUG CONTROL.short
12598516_ADF DRUG CONTROL.short

... That is, if they aren’t used in large doses, or they aren’t used too often. Most illegal drug users are occasional or opportunistic dabblers, ...
Pharmacologic Treatments - University of Kentucky | Medical Center
Pharmacologic Treatments - University of Kentucky | Medical Center

... • For TCA, improvement may be attributed to the sedative effects • Low doses TCA useful, e.g. cyclobenzaprine 10-30 mg or ...
Depressant Drugs
Depressant Drugs

... taking one dose of one depressant drug and one dose of another may have a combined effect of three doses, or seven or even more. Depressants used in combination create effects which multiply: one plus one does NOT equal two. The more potent or stronger the depressant, the more likely that this react ...
Hryhorova Margaryta Sokol Oleksandra Ananko Svitlana A
Hryhorova Margaryta Sokol Oleksandra Ananko Svitlana A

... Kharkiv National Medical University (Department of Pharmacology and Drug Prescription) Kharkiv. Ukraine Looking at the statistics of adolescent’s ENT diseases we marked, that there are some cases when subjective tinnitus appears. This condition is caused by sensorineural hearing impairment. We tried ...
Citeline Pharma R&D Annual Review 2015 Supplement: New Active
Citeline Pharma R&D Annual Review 2015 Supplement: New Active

... molecules coming to fruition – fuelled in no small part by the explosive revolution in the hepatitis-C market. There were no fewer than seven new drugs for this disease reaching the market; now all the industry has to do is work out how to get them to all of the patients who would benefit from them. ...
Viamet to Present at American Chemical Society National Meeting
Viamet to Present at American Chemical Society National Meeting

... August 12, 2015, Research Triangle Park, North Carolina – Viamet Pharmaceuticals, Inc. today announced that an overview of the Company’s metalloenzyme chemistry and biology technology will be presented at the American Chemical Society (ACS) National Meeting, to be held from August 16-20, 2015, in Bo ...
Pharmacy Technician*s Course. LaGuardia Community College
Pharmacy Technician*s Course. LaGuardia Community College

... into disuse over the decades due to their toxicity in overdose. As little as 1,000 mg of nortriptyline has resulted in fatal overdoses  SSRI or selective serotonin reuptake inhibitors are now most commonly used. Examples include: Fluoxetine (Prozac®), Paroxetine (Paxil®)  SSRIs have been used for ...
fda
fda

... The Obama fda is likely to act on this. After all, this is the agency that threatened to regulate Cheerios as a drug because General Mills advertised its cereal’s health benefits, flipped out because Google searches of some drug makers’ websites do not always bring up dire warnings about their produ ...
Available Tools to Facilitate Early Patient Access to
Available Tools to Facilitate Early Patient Access to

... programmes and pilots available to facilitate a more continuous and iterative dialogue between regulators, applicants and other stakeholders during the whole drug development cycle. In the USA, drugs that treat unmet medical needs, either by providing a therapy for an indication for which there are ...
Explanation
Explanation

... Use of drugs that results in physiological or psychological harm to the user (purposes other than those intended in medicine.) Explanation: ...
Review Questions on Basic Pharmacology
Review Questions on Basic Pharmacology

... Review Questions on Basic Pharmacology. Make a list of your answers & then check them against the Answer Key 1. An antagonist is a type of drug that: A.has maximal efficacy B.has affinity for a receptor but little efficacy C.binds to a receptor and activates it D.has efficacy but low affinity E.decr ...
Generic Drugs - CN Pensioners` Association
Generic Drugs - CN Pensioners` Association

... ensuring the lowest priced drug is dispensed on your next pharmacy visit. Should your healthcare professional prescribe you a brand name drug with “No Substitution” indicated, your pharmacist may contact them to confirm if the generic drug can be dispensed instead, ensuring you are not require ...
Addictive behaviour and behavioural change
Addictive behaviour and behavioural change

... • Norms are socially derived, serve to locate people within groups and control the interactions between them. • Social contexts largely drive group behaviours. • Studies repeatedly show “peer pressure” as the major influence on uptake of drug use. ...
Neurotransmission - AP Psychology Community
Neurotransmission - AP Psychology Community

... • Love seems to not be an emotion but a drive to seek pleasure. ...
What is in a name
What is in a name

... – Though basic ingredients are same, the “fillers” may be different (fillers may effect speed drug is dissolved or ...
thalidomide - Universidade Nova de Lisboa
thalidomide - Universidade Nova de Lisboa

...  FDA inspector Frances Kelsey considered the application for thalidomide ...
The Benefits of Bacillus-derived Hyaluronic Acid
The Benefits of Bacillus-derived Hyaluronic Acid

... as with the Streptococcus fermentation process, it results in a heterogeneous mix of polymers without the ability to distinguish between high and low molecular weight. From the outset, it was essential that a technique was found to modify all elements of filtration including flow, process times and ...
classification of antipsychotic drugs
classification of antipsychotic drugs

... The antipsychotic drugs probably owe their therapeutic effects mainly to blockade of D2 receptors. The main groups, phenothiazines, thioxanthines and butyrophenones, show preference for D2 over D1 receptors; some newer agents (e.g. remoxipride) are highly selective for D2 receptors, whereas clozapin ...
Drugs for Gastrointestinal Disorders Duodenal Ulcer Gastric Ulcers
Drugs for Gastrointestinal Disorders Duodenal Ulcer Gastric Ulcers

...  Patients should be advised not to take antacids at the same time as H2-receptor blockers ...
Activities 1
Activities 1

... powder. It is smoked, sniffed or injected and makes people feel very relaxed, content, and cut off from the world. It is highly addictive, even if not injected. There is also the extra risk of getting liver disease (hepatitis) or HIV infection, which can lead to aids. Over-the-counter codeine medica ...
1st and 2nd Lectures
1st and 2nd Lectures

... in the same area, or from drugs already in clinical use? iii. Is it likely that an esoteric drug delivery system will be required, and if so, can this be developed? iv. If the drug is successfully developed, is the expected market sufficient to justify the cost of development? ...
< 1 ... 128 129 130 131 132 133 134 135 136 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report